Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP807898.RAS0VcEQxus1ID6dDzGWkehzYEQppWARTitPwEC9_HrXs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP807898.RAS0VcEQxus1ID6dDzGWkehzYEQppWARTitPwEC9_HrXs130_assertion type Assertion NP807898.RAS0VcEQxus1ID6dDzGWkehzYEQppWARTitPwEC9_HrXs130_head.
- NP807898.RAS0VcEQxus1ID6dDzGWkehzYEQppWARTitPwEC9_HrXs130_assertion description "[In patients with CD, CD4+ T cells that express NKG2D produced high levels of interleukin (IL)-17 and IL-22 and expressed high levels of CCR6, the IL-23 receptor, CD161, and RORC (a transcription factor that regulates expression of Th17 cytokines).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807898.RAS0VcEQxus1ID6dDzGWkehzYEQppWARTitPwEC9_HrXs130_provenance.
- NP807898.RAS0VcEQxus1ID6dDzGWkehzYEQppWARTitPwEC9_HrXs130_assertion evidence source_evidence_literature NP807898.RAS0VcEQxus1ID6dDzGWkehzYEQppWARTitPwEC9_HrXs130_provenance.
- NP807898.RAS0VcEQxus1ID6dDzGWkehzYEQppWARTitPwEC9_HrXs130_assertion SIO_000772 21600899 NP807898.RAS0VcEQxus1ID6dDzGWkehzYEQppWARTitPwEC9_HrXs130_provenance.
- NP807898.RAS0VcEQxus1ID6dDzGWkehzYEQppWARTitPwEC9_HrXs130_assertion wasDerivedFrom befree-20140225 NP807898.RAS0VcEQxus1ID6dDzGWkehzYEQppWARTitPwEC9_HrXs130_provenance.
- NP807898.RAS0VcEQxus1ID6dDzGWkehzYEQppWARTitPwEC9_HrXs130_assertion wasGeneratedBy ECO_0000203 NP807898.RAS0VcEQxus1ID6dDzGWkehzYEQppWARTitPwEC9_HrXs130_provenance.